Placebo News and Research

RSS

Impact of orally administered cannabidiol (CBD) on fitness and health among healthy adult individuals

Researchers evaluated the effects of oral CBD administration on the health and fitness of healthy adults.

9 Jun 2023

First-in-class drug shows promise as a safe and effective treatment for cannabis use disorder

A first-in-class drug engineered to selectively inhibit the signaling pathway of the cannabinoid receptor shows promise as a safe and effective treatment for cannabis use disorder (CUD), a condition where a person is unable to control their cannabis use, even though it's causing problems in their lives.

8 Jun 2023

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

A clinical trial led by Yale Cancer Center shows that the drug osimertinib, a targeted therapy for non-small cell lung cancer, improved rates of survival and reduced risk of recurrence in patients after surgery.

7 Jun 2023

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

Orally administered semaglutide shows significant efficacy in reducing HbA1c and body weight in patients with type 2 diabetes compared to other treatments. The study includes a large number of participants from multiple trials.

7 Jun 2023

Drinking beetroot juice every day linked to reduced risk of repeat procedures and heart attacks in angina patients with stents

Drinking beetroot juice every day for six months after having a stent fitted reduced the chance of angina patients having a heart attack or needing a repeat procedure, according to new research presented at the British Cardiovascular Society conference.

6 Jun 2023

Researchers test nitroglycerin patch as treatment for menopausal women experiencing hot flashes

Women have long searched for remedies for the bothersome hot flashes that often come with menopause.

5 Jun 2023

Flavanol consumption improves hippocampal memory function associated with cognitive aging

Researchers investigated the impact of dietary flavanols on cognitive aging.

5 Jun 2023

Study suggests possible new treatment option for people with slow-growing but deadly brain tumor

In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening.

4 Jun 2023

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis.

2 Jun 2023

Experts voice the need for comparing traditional clinical trials to decentralized trials

There's one question that Hollings Cancer Center researcher Jennifer Dahne, Ph.D., co-director of the remote and virtual trials program at the South Carolina Clinical & Translational Research Institute, hears more than any other as she consults with clinical researchers about how to set up remote trials, also known as decentralized trials. Will these trials overcome the barriers that make it difficult for minority and underserved populations to participate in clinical trials? It's also a question she often discusses with her peers at other academic medical centers that are also home to Clinical and Translational Science Award hubs.

2 Jun 2023

Eye drops to slow the progression of nearsightedness in kids could be on the horizon

The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.

1 Jun 2023

Parkinson's disease drug ropinirole is safe and tolerable for ALS patients, early clinical trial shows

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles.

1 Jun 2023

Treatment with modified lactic acid bacteria accelerates the healing of wounds, study shows

Complicated, hard-to-heal wounds are a growing medical problem and there are currently only two drugs approved with proven efficacy.

30 May 2023

Memory boost with multivitamins: Study reveals improved cognitive function in older adults

Researchers investigate whether one year of supplementation with multivitamins could improve hippocampus-mediated cognition and memory in older adults.

29 May 2023

Diet low in flavanols linked to age-related memory loss

A large-scale study led by researchers at Columbia and Brigham and Women's Hospital/Harvard is the first to establish that a diet low in flavanols-;nutrients found in certain fruits and vegetables-;drives age-related memory loss.

29 May 2023

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with rectal, brain, and kidney cancers. The results of these studies, along with dozens of others led by Dana-Farber researchers, will be presented at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

26 May 2023

IV plus PA corticosteroids may improve key indicators of functional recovery after total knee arthroplasty

For patients undergoing total knee arthroplasty (TKA), a combination of intravenous and periarticular corticosteroids does not improve pain control – but, may improve key indicators of functional recovery in the days after surgery, reports a trial in The Journal of Bone & Joint Surgery.

25 May 2023

Placebo effect in technical applications increases risk-taking behavior

Human augmentation technologies refer to technological aids that enhance human abilities. They include things like exoskeletons, but also augmented reality headsets.

25 May 2023

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the IAVI G001 Phase 1 clinical trial to test the safety and immune response of a self-assembling nanoparticle HIV vaccine.

25 May 2023

Daily multivitamin supplementation holds promise to protect cognitive health in older adults

Few effective strategies have been shown in randomized clinical trials to improve memory or slow cognitive decline among older adults.

25 May 2023

Placebo News and Research

Impact of orally administered cannabidiol (CBD) on fitness and health among healthy adult individuals

First-in-class drug shows promise as a safe and effective treatment for cannabis use disorder

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

Drinking beetroot juice every day linked to reduced risk of repeat procedures and heart attacks in angina patients with stents

Researchers test nitroglycerin patch as treatment for menopausal women experiencing hot flashes

Flavanol consumption improves hippocampal memory function associated with cognitive aging

Study suggests possible new treatment option for people with slow-growing but deadly brain tumor

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Experts voice the need for comparing traditional clinical trials to decentralized trials

Eye drops to slow the progression of nearsightedness in kids could be on the horizon

Parkinson's disease drug ropinirole is safe and tolerable for ALS patients, early clinical trial shows

Treatment with modified lactic acid bacteria accelerates the healing of wounds, study shows

Memory boost with multivitamins: Study reveals improved cognitive function in older adults

Diet low in flavanols linked to age-related memory loss

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

IV plus PA corticosteroids may improve key indicators of functional recovery after total knee arthroplasty

Placebo effect in technical applications increases risk-taking behavior

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Daily multivitamin supplementation holds promise to protect cognitive health in older adults

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest News